Fortitude Family Office’s CareDx CDNA Stock Holding History

Fortitude Family Office’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827	Hold	29	–	–	﹤0.01%	1817
2026 Q1	$503	Buy	+29	New	+$549	﹤0.01%	1730

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fortitude Family Office's CDNA Position: Q2 2026 in Review

Fortitude Family Office held its CareDx (CDNA) position steady in Q2 2026 at 29 shares worth $827. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Fortitude Family Office first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Fortitude Family Office held 29 shares of CareDx worth $827 as of Q2 2026.
Fortitude Family Office left its CareDx share count unchanged in Q2 2026.
CareDx made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1817 holding.
Fortitude Family Office first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.